Screening for blood born viruses in assisted reproduction: is annual testing necessary?
Eran GoldYossi MizrachiAmir ShalevJacob FarhiEran HorowitzAmir RavhonSarit AlushDavid LevranArie RazielAriel WeissmanPublished in: Archives of gynecology and obstetrics (2019)
Primary infection with HBV, HCV, or HIV is an extremely rare event among Israeli infertile patients, and the risk for seroconversion in this population is practically nil. Annual screening of both partners leads to substantial costs and appears to be futile. Our results question the current practice and support increasing the interval between screening tests in low-risk populations.
Keyphrases
- hepatitis c virus
- end stage renal disease
- human immunodeficiency virus
- newly diagnosed
- healthcare
- chronic kidney disease
- hepatitis b virus
- ejection fraction
- primary care
- antiretroviral therapy
- hiv positive
- prognostic factors
- type diabetes
- hiv aids
- polycystic ovary syndrome
- south africa
- patient reported outcomes
- patient reported
- preterm birth